Navigation Links
BioMS Medical announces third quarter 2007 results
Date:11/14/2007

Toronto Stock Exchange Symbol: MS

EDMONTON, Nov. 14 /PRNewswire-FirstCall/ - BioMS Medical Corp (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced financial and operational results for the third quarter, ended September 30, 2007.

"During the quarter, we continued to maintain momentum towards the commercialization of our lead drug, MBP8298, for the treatment of multiple sclerosis," said Kevin Giese, President and CEO of BioMS Medical.

Third Quarter 2007 Highlights:

- The independent Data Safety Monitoring Board (DSMB) for MINDSET-01,

the Company's on-going phase II trial of MBP8298 for relapsing-

remitting MS, completed a safety analysis and recommended that the

trial continue as per protocol. This double blind phase of this trial

is expected to complete in the second half of 2008.

- Subsequent to the end of the quarter,

- Two posters presented at the 23rd Congress of the European

Committee for Treatment and Research in Multiple Sclerosis

(ECTRIMS) in Prague, Czech Republic, in respect of the phase

III MAESTRO-01 secondary progressive MS (SPMS) study, showed

that over 70% of the screened patients had the drug's target

HLA DR2 and/or DR4 responder genes, and that an interim

analysis showed no significant safety concerns with the drug.

An interim safety and efficacy analysis for MAESTRO-01 is

planned for mid-2008.

- The Company announced that the U.S. pivotal phase III SPMS

trial, MAESTRO-03, is on track for full enrollment in 2008, and

completed enrollment of the first 133 patients who will form

the basis of an interim analysis that is expected in 2009.

Financial Results

The consolidated net loss for the three months ended
'/>"/>

SOURCE BioMS Medical Corp.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. BioMS Medical announces its intention to renew a normal course issuer bid
2. BioMS Medical to present at BioContact 2007
3. BioMS Medicals relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board
4. BioMS Medical achieves enrollment milestone in U.S. phase III multiple sclerosis trial
5. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
6. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
7. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
8. Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
9. Dr. Amit Dhawan Promoted to Medical Director for The Mattson Jack Group
10. ATS Medical Expands Open Pivot Heart Valve Offerings
11. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... BOSTON, MA (PRWEB) December 23, 2014 ... generation webinar series is designed to introduce ... and inform users and partners of platform ... features and benefits; empowering users in their ... and powerful tools. , According to SoundConnect’s ...
(Date:12/24/2014)... New York (PRWEB) December 23, 2014 According ... the Long Island Affiliate of ITRA Global, the national office ... but steady recovery. This is evidenced by the third ... strong stock market. Low energy costs have held inflation ... The only negative is the housing market remaining soft. , ...
(Date:12/24/2014)... Nashville, Tenn. (PRWEB) December 23, 2014 ... Hill was elected treasurer for the American Society ... to advancing knowledge and research in reproductive medicine. ... fills a seat on the executive board and will ... , Dr. Hill has actively supported ASRM since ...
(Date:12/24/2014)... San Diego, CA (PRWEB) December 23, 2014 ... Contest where their Twitter followers can submit their ... for themselves and their lab mates. , For those ... beloved lab mates, the Pipette.com Holiday in the Lab ... encourages Pipette.com Twitter followers to send pictures ...
Breaking Biology Technology:SoundConnect Launches Leading Edge Business Communications Webinar Series 2SoundConnect Launches Leading Edge Business Communications Webinar Series 3ITRA Global Reports Long Island Is Out of Sync With The National Office Market 2ITRA Global Reports Long Island Is Out of Sync With The National Office Market 3Nashville Fertility Center Announces Dr. George A. Hill Selected to Serve as ASRM Treasurer for 2014-15 2Nashville Fertility Center Announces Dr. George A. Hill Selected to Serve as ASRM Treasurer for 2014-15 3Major Pipette Distributor Pipette.com Announces their Holiday in the Lab Contest 2
... CHERTSEY, England, Dec. 27, 2011  United Therapeutics Corporation ... subsidiary, United Therapeutics Europe, Ltd., announced today that ... Securite Sanitaire des Produits de Sante (AFSSAPS) ... the treatment of pulmonary arterial hypertension (PAH).  Remodulin ...
... WEST LAFAYETTE, Ind. Researchers have shown ... manipulate light in new ways that could make possible a ... and computers., The researchers ... property of light called its phase. Light is transmitted as ...
... 2011 In recognition of the International Year of Chemistry ... The Changing Role of Chemistry in Drug Discovery . ... with insights from industry experts, the new report forecasts the ... report suggests, a much more targeted, patient-specific approach will define ...
Cached Biology Technology:Intravenous Remodulin Approved for the Treatment of Pulmonary Arterial Hypertension in Most of the European Union 2Intravenous Remodulin Approved for the Treatment of Pulmonary Arterial Hypertension in Most of the European Union 3Intravenous Remodulin Approved for the Treatment of Pulmonary Arterial Hypertension in Most of the European Union 4Intravenous Remodulin Approved for the Treatment of Pulmonary Arterial Hypertension in Most of the European Union 5'Nanoantennas' show promise in optical innovations 2'Nanoantennas' show promise in optical innovations 3Thomson Reuters Research Forecasts the Onset of the Targeted Drug Discovery Era 2Thomson Reuters Research Forecasts the Onset of the Targeted Drug Discovery Era 3
(Date:12/17/2014)... Valencell, a leader in performance biometric data ... industry leaders such as Intel, Jabra, Atlas, and Scosche ... products. These products will be showcased at CES 2015, ... . "Our partners choose PerformTek ... – with the clinical data to back it up," ...
(Date:12/17/2014)... -- Automation is fundamentally transforming the travel experience and ... borders. Over the past decade, ePassports, biometric readers, ... to self process through border control via eGates ... increasing number of airports, seaports, and land borders ... Maxine Most , Principal at Acuity Market ...
(Date:12/11/2014)... --Research and Markets , ... ) has announced the addition of the ... to their offering. One major ... technology. With continuous advances in technology, it is ... standard that meets the needs and expectations of ...
Breaking Biology News(10 mins):Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
... crystallised a protein that may help gut bacteria bind to the ... identify strains that are likely to be of real benefit to ... to have a beneficial effect, and if they attach to surfaces ... enough to exert their activity," says Dr Nathalie Juge from the ...
... College of Medical Toxicology (ACMT) have signed an agreement to ... Toxicology (JMT), the official journal of the ACMT, beginning ... University of Pennsylvania Press. The Journal of ... advancing the science and practice of medical toxicology. The ...
... food is a matter of debate. A high-profile study a ... of their carbon from trees and leaves, evidence for a ... But new research from the University of Washington shows this ... richer diet for fish and other aquatic life, according to ...
Cached Biology News:A sticky solution for identifying effective probiotics 2Springer and the American College of Medical Toxicology to work together 2Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3
Weinreb Linker...
...
Rabbit polyclonal to M13 Bacteriophage Coat Proteins ( Abpromise for all tested applications)....
Recognizes the 41 and 43 kDa G-proteins present in liver plasma membranes and Gq/11alpha expressed in the Sf9 insect cell expression system. Negative for recombinant G(I)alpha subtypes....
Biology Products: